Clinical Trial

Analysis of Ocular Surface Microbiota in Dry Eye Patients After Femtosecond Laser-assisted In-situ Keratomileusis (FS-LASIK)

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 31, 2024 (before its estimated October 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
By using 16S rRNA sequencing technology to analyze the changes in ocular surface microbiota before and after surgery, as well as the impact of changes in ocular surface microbiota on FS-LASIK induced DES, new treatment ideas are provided for corneal FS-LASIK induced DES patients, and the incidence of FS-LASIK related DES is reduced.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06448468
Lead Sponsor Second Affiliated Hospital of Nanchang University
Conditions Refractive Surgery
Enrollment 200 participants
Start Date 2024-05-01
Primary Completion 2024-10-01 (estimated)
Study Completion 2024-11-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-31